Ekta Verma

Ekta Verma

Auto-generated profile, based on publicly available information

Ekta Verma

Laboratory of Microbial Genetics, Department of Botany, Banaras Hindu University, Varanasi, India

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in International Biodeterioration & Biodegradation
Verified
Journal Article
Closed access
BTBalkrishna Tiwari
Balkrishna Tiwari
EVEkta Verma
Ekta Verma
SCSindhunath Chakraborty
Sindhunath Chakraborty
ASAlok Kumar Srivastava
Alok Kumar Srivastava
AMArun Mishra
Arun Mishra

31 May 2018 in International Journal of Environmental Science and Technology
Verified
Journal Article
Closed access
PDF file
EVE. Verma
E. Verma
SSS. Singh
S. Singh
NINiveshika
Niveshika
AMArun Mishra
Arun Mishra

17 October 2016 in Physiology and Molecular Biology of Plants
Verified
Journal Article
Closed access
PDF file
SSSavita Singh
Savita Singh
EVEkta Verma
Ekta Verma
BTBalkrishna Tiwari
Balkrishna Tiwari
AMArun Mishra
Arun Mishra

29 November 2016 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
NINiveshika
Niveshika
EVEkta Verma
Ekta Verma
AMArun Mishra
Arun Mishra
ASAngad K. Singh
Angad K. Singh
VSVinay K. Singh
Vinay K. Singh
Cyanobacteria are rich source of array of bioactive compounds. The present study reports a novel antibacterial bioactive compound purified from cyanobacterium Nostoc sp. MGL001 using various chromatographic techniques viz. thin layer chromatography (TLC) and high performance liquid chromatography (HPLC). Further characterization was done using electrospray ionisation mass spectroscopy (ESIMS) and nuclear magnetic resonance (NMR) and predicted structure of bioactive compound was 9-Ethyliminomethyl-12-(morpholin - 4 - ylmethoxy) -5, 8, 13, 16 – tetraaza – hexacene - 2, 3 dicarboxylic acid (EMTAHDCA). Structure of EMTAHDCA clearly indicated that it is a novel compound that was not reported in literature or natural product database. The compound exhibited growth inhibiting effects mainly against the gram negative bacterial strains and produced maximum zone of inhibition at 150 μg/mL concentration. The compound was evaluated through in silico studies for its ability to bind 30S ribosomal fragment (PDB ID: 1YRJ, 1MWL, 1J7T and 1LC4) and OmpF porin protein (4GCP, 4GCQ and 4GCS) which are the common targets of various antibiotic drugs. Comparative molecular docking study revealed that EMTAHDCA has strong binding affinity for these selected targets in comparison to a number of most commonly used antibiotics. The ability of EMTAHDCA to bind the active sites on the proteins and 30S ribosomal fragments where the antibiotic drugs generally bind indicated that it is functionally similar to the commercially available drugs.

4 February 2019 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
SCSindhunath Chakraborty
Sindhunath Chakraborty
AMAditi Mishra
Aditi Mishra
EVEkta Verma
Ekta Verma
BTBalkrishna Tiwari
Balkrishna Tiwari
AMArun K. Mishra
Arun K. Mishra
SSSatya Shila Singh
Satya Shila Singh

1 January 2019
Verified
Book Chapter
Closed access
SCSindhunath Chakraborty
Sindhunath Chakraborty
EVEkta Verma
Ekta Verma
SSSatya Shila Singh
Satya Shila Singh